Quantum computing technology is still on the drawing board, but its vast potential to crack encryption codes means that organizations today should already consider its threats to their most sensitive business data, according to a report from supply chain resilience provider apexanalytix.The...
Total intermodal volume fell 2.0% year-over-year in the fourth quarter of 2025, according to the Intermodal Association of North America (IANA).The slip came as domestic container originations grew 2.2%, but international containers dropped 4.7%, and trailers dropped 23.1%“While aggregate...
We’ve all seen this before: a developer deploys a new cloud workload and grants overly broad permissions just to keep the sprint moving. An engineer generates a “temporary” API key for testing and forgets to revoke it. In the past, these were minor operational risks, debts you’d...
Cybersecurity researchers have disclosed details of a new Android trojan called Massiv that’s designed to facilitate device takeover (DTO) attacks for financial theft. The malware, according to ThreatFabric, masquerades as seemingly harmless IPTV apps to deceive victims, indicating that...
The cyber threat space doesn’t pause, and this week makes that clear. New risks, new tactics, and new security gaps are showing up across platforms, tools, and industries — often all at the same time. Some developments are headline-level. Others sit in the background but carry long-term impact....
Recently in BioTechniques, we’ve presented the development of a biomarker assay for the quantification of CXCL9 in human serum, an enhanced Southern blotting protocol for evaluating transgene integration sites and integrity, and the optimization of a method for proximity labeling in brain...
Original story from Shanghai Jiao Tong University Journal Center (Shanghai, China). Melatonin and zinc oxide nanoparticles may protect male reproductive health during chemotherapy, study suggests. A recent study in Reproductive and Developmental Medicine shows that combining melatonin with zinc...
Cytokinetics’ heart disease drug secured European approval. Elsewhere, Teva and Sanofi reported longer-term data from an experimental therapy targeting ulcerative colitis and Crohn’s disease.
Continue reading →